Aclarion, Inc. Share Price & Technical Analysis
ACON · $3.45 (-1.43%)
Healthcare / Health Information Services
$3.45
-1.43%
Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protoco…
Price chart
Seasonality
Jun has 2 positive and 3 negative years (last 5 years shown)
3% return in Jun, -6% avg return in past 3 year Jun month.
-23% return in 2026, -193% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -30% | -18% | 22% | 3% | -3% | 3% | – | – | – | – | – | – | -23% |
| 25 | -85% | -52% | -94% | -40% | 3% | 19% | -9% | 1% | 9% | 1% | -16% | -28% | -292% |
| 24 | -25% | -83% | -15% | -10% | 1% | -11% | 10% | -34% | -10% | -2% | -2% | -20% | -200% |
| 23 | 5% | 14% | -4% | -3% | 64% | -25% | -23% | -29% | -33% | -4% | -21% | -27% | -86% |
| 22 | – | – | – | -29% | -37% | -32% | 5% | 11% | -27% | 23% | -32% | -27% | -146% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and imaging data transfer products, including AMBRA Healthcare, a data transfer platform. In addition, the company offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra, and performs various degenerative pain biomarker calculations from those spectra, for each disc examined; and NOCIGRAM, which further processes the NOCICALC results into individual NOCISCORES, on a 0-10 scale, that represent the different relative levels of degenerative pain biomarkers the various discs examined in the patient. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$8.17M
P/E ratio
—
52W high
$12.03
52W low
$2.34
Volume
49,214
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is Aclarion, Inc. share price today?
- Aclarion, Inc. (ACON) last traded around $3.45 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ACON have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ACON. Download the app for real-time alerts.
- How can I analyze Aclarion, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.